Presence of two enzymes, different from the F1F0-ATPase, hydrolyzing nucleotides in human term placental mitochondria.
The hydrolysis of ATP, ADP or GTP was characterized in mitochondria and submitochondrial particles since a tightly-bound ATPase associated with the inner mitochondrial membrane from the human placenta has been described. Submitochondrial particles, which are basically inner membranes, were used to define the location of this enzyme. Mitochondria treated with trypsin and specific inhibitors were also used. The oxygen consumption stimulated by ATP or ADP was 100% inhibited in intact mitochondria by low concentrations of oligomycin (0.5 microgram/mg) or venturicidine (0.1 microgram/mg), while the hydrolysis of ATP or ADP was insensitive to higher concentrations of these inhibitors but it was inhibited by vanadate. Oligomycin or venturicidine showed a different inhibition pattern in intact mitochondria in relation to the hydrolysis of ATP, ADP or GTP. When submitochondrial particles were isolated from mitochondria incubated with oligomycin or venturicidine, no further inhibition of the nucleotide hydrolysis was observed, contrasting with the partial inhibition observed in the control. By incubating the placental mitochondria with trypsin, a large fraction of the hydrolysis of nucleotides was eliminated. In submitochondrial particles obtained from mitochondria treated with trypsin or trypsin plus oligomycin, the hydrolysis of ATP was 100% sensitive to oligomycin at low concentrations, resembling the oxygen consumption; however, this preparation still showed some ADP hydrolysis. Native gel electrophoresis showed two bands hydrolyzing ADP, suggesting at least two enzymes involved in the hydrolysis of nucleotides, besides the F1F0-ATPase. It is concluded that human placental mitochondria possesses ADPase and ATP-diphosphohydrolase activities (247).
Uribe
A
A
Departamento de Bioquimica, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico D.F., Mexico.
Flores-Herrera
O
O
Rendón
J L
JL
Espinosa-Garcia
M T
MT
Martinez
F
F
D000255:Adenosine Triphosphate / Q000378:metabolism; D004586:Electrophoresis / Q000379:methods; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D006801:Humans; D006868:Hydrolysis; D066298:In Vitro Techniques; D008928:Mitochondria / Q000187:drug effects / Q000201:enzymology* / Q000648:ultrastructure; D009711:Nucleotides / Q000378:metabolism* / Q000494:pharmacology; D009840:Oligomycins / Q000494:pharmacology; D009994:Osmolar Concentration; D010101:Oxygen Consumption; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy; D006180:Proton-Translocating ATPases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013997:Time Factors; D014357:Trypsin / Q000378:metabolism / Q000494:pharmacology; D014638:Vanadates / Q000494:pharmacology; D014698:Venturicidins / Q000494:pharmacology
D004791:Enzyme Inhibitors; D009711:Nucleotides; D009840:Oligomycins; D014698:Venturicidins; D014638:Vanadates; D000255:Adenosine Triphosphate; D014357:Trypsin; D006180:Proton-Translocating ATPases